Live
- Farmers’ loan waiver by August 15: Revanth
- MyVoice: Views of our readers 24th April 2024
- Nasa to overhaul mission MSR – here’s why it must
- ‘Military strength, capabilities necessary to prevent wars’
- Youths indifference to voting is unhealthy for democracy
- Actress Rithika and models inaugurate Sutraa Lifestyle Exhibition
- Loud campaign
- Faculty students celebrated english literature day in Government Degree College
- Huge fire accident.. Shops of street vendors burnt in the fire
- Pawan Kalyan promises to protect the coastal area from sea erosion
'Heterologous Booster Dose' enhances protection against Covid: AIG report
‘Heterologous Booster Dose’ enhances protection against Covid: AIG report
A study taken up by the AIG Hospitals found that after two doses of vaccination, having a booster dose of a different company would enhance the protection against Omicron variants.
Hyderabad: A study taken up by the AIG Hospitals found that after two doses of vaccination, having a booster dose of a different company would enhance the protection against Omicron variants.
The Hospital tried a booster dose of a different company, what they call this phenomenon is 'Heterologous booster dose' with Corbevax (by BiologicalE) on about 250 patients and it showed that the immunity levels tremendously increased in the patients.
The study titled 'Heterologous Booster Dose with CORBEVAX Following Primary Vaccination with COVISHIELD has shown that it enhances Protection against SARS-CoV-2' was published in the high-impact factor journal 'Vaccines,' said AIG Hospital Chairman Dr D Nageshwar Reddy.
